Glucose Testing in Hospital Environments
In critical care settings, tight glucose control is not just for diabetics.
Read MorePosted by Elaine Sanchez Wilson | Apr 2, 2015 | Clinical Chemistry |
In critical care settings, tight glucose control is not just for diabetics.
Read MorePosted by Jenny Lower | Mar 3, 2015 | Cancer |
Experts from the clinical lab community gathered on January 8–9, 2015, to comment on FDA’s proposed regulatory structure for laboratory-developed tests. This selection of comments from the first day of the workshop offers a glimpse into the depth of participants’ observations.
Read MorePosted by Jenny Lower | Feb 25, 2015 | Cardiovascular |
Developments in lipid testing over recent years may signal a better alternative to taking cholesterol levels when it comes to evaluating patients at risk for cardiovascular events.
Read MorePosted by Jenny Lower | Feb 4, 2015 | Cancer |
President Obama’s announcement of a new precision medicine initiative in his State of the Union address has significant implications for the clinical laboratory community.
Read MorePosted by Jenny Lower | Dec 31, 2014 | Kidney Disease, Uncategorized |
To determine how recommendations for chronic kidney disease testing in laboratory and point-of-care environments are shifting, CLP spoke to Robert H. Christenson, PhD, professor of pathology and medical and research technology at the University of Maryland School of Medicine and past president of the American Association for Clinical Chemistry.
Read More